This inventor holds 4 USPTO granted patents. Top assignees: Glaxo Group Limited, Glaxo Wellcome Inc.. Active years: 1999-2003.
Company Filing History:
Years Active: 1999-2003
Title: Surekha Podduturi: Innovator in Hematological Treatments
Introduction
Surekha Podduturi is a prominent inventor based in San Jose, CA (US). She has made significant contributions to the field of hematology through her innovative research and development of therapeutic peptides. With a total of 4 patents, her work focuses on addressing critical medical conditions, particularly thrombocytopenia.
Latest Patents
Among her latest patents, Surekha has developed labeled compounds that bind to a thrombopoietin receptor. These peptides and peptide mimetics are designed to activate the thrombopoietin receptor, which is crucial for treating hematological disorders. Her inventions are particularly beneficial for patients suffering from thrombocytopenia due to chemotherapy, radiation therapy, or bone marrow transfusions. Additionally, her work includes diagnostic methods that utilize labeled peptides and peptide mimetics.
Career Highlights
Throughout her career, Surekha has worked with notable companies such as Glaxo Group Limited and Glaxo Wellcome Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation in the medical field.
Collaborations
Surekha has collaborated with esteemed colleagues, including William J Dower and Ronald W Barrett. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Surekha Podduturi's innovative work in developing therapeutic peptides for hematological disorders showcases her dedication to improving patient outcomes. Her contributions to the field are invaluable and continue to pave the way for advancements in medical treatments.